logo
logo

Investors Alerted to Class Action Against Intellia Therapeutics

Business and Finance
‌
‌
sparksAI summary
Display highlights
  • Class action lawsuit filed against Intellia Therapeutics by Bronstein, Gewirtz & Grossman, LLC
  • Allegations of misleading statements regarding NTLA-3001's development and marketing viability
  • Investors can join the case until April 14, 2025, at no cost
  • Bronstein, Gewirtz & Grossman, LLC representing investors in securities fraud class action
360 summary
  • If you suffered a loss in QCI, you have until April 28, 2025, to request that the Court appoint you as lead plaintiff.
  • Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
  • We represent investors in class actions on a contingency fee basis, meaning you won't incur any costs unless there is a successful recovery.
Business InsiderBusiness Insider
  • Investors who suffered losses in Intellia have until April 14, 2025, to request to be appointed as lead plaintiff without incurring any costs.
  • Bronstein, Gewirtz & Grossman, LLC operates on a contingency fee basis, seeking reimbursement for expenses and fees only if successful in recovering funds for investors.
  • The law firm has a track record of recovering hundreds of millions of dollars for investors in securities fraud class actions and shareholder derivative suits.
Business InsiderBusiness Insider
Explore
The above information is compiled by Business Insider and does not represent any position of Arbor. It does not constitute any investment advice made by Arbor. Before making any investment decisions, investors should consider the risk factors related to the investment products based on their own circumstances and seek advice from professional investment advisors if necessary. We strive to ensure but cannot guarantee the truthfulness, accuracy, and originality of the above content, and we make no promises or guarantees in this regard. As machine learning has a probabilistic nature, it may lead to incorrect reflection of facts in certain situations. You should appropriately evaluate the accuracy of any information summary based on your usage, including through manual evaluation of the information summary. We are not responsible for any losses or liabilities incurred by you due to your use, viewing, and access of the platform or failure to do so.
mobile

Remove Duplicated Information

app-iconLess is More
app-icon
Applicable for iOS and Android systems
Follow Us
logo
All rights reserved © 2025 Arbor.